Varian Medical Systems, a medical software and device manufacturer, recently awarded the American Board of Radiology Foundation a $100,000 grant in support of a national brachytherapy registry. Many of Varian's products focus on radiation-based cancer treatment for patients.
The new registry is designed to collect information on the different types of radiation-based treatments that patients across the United States receive for cancer. The registry is part of a voluntary effort to recognize oncologists in the United States. In addition, the registry is designed to improve patient outcomes through open access to information about different treatment options.
The new registry focuses on brachytherapy. Brachytherapy is a type of radiation-based treatment that uses focused beams of energy to shrink targeted tumors. One of the main advantages of brachytherapy is that it can accurately target the site of a tumor. This minimizes damage to healthy tissue around a tumor. Many traditional chemotherapy treatment programs can cause systemic damage to other parts of the body. With targeted treatment, it's possible to minimize this collateral damage.
Varian is based in Palo Alto, California. Its medical device product line includes linear accelerators; these devices are used to treat millions of cancer patients all around the world. In addition, the oncology systems branch of the company delivers a wide variety of radiotherapy drugs that are used in the treatment of cancer. According to a press release by the company, Varian is directly involved in 100 currently-active radiation-therapy research projects across the globe.